期刊文献+

新生儿重症监护病房抗感染药的使用及耐药分析 被引量:6

Analysis of Antibiotics Application and Drug Tolerance in Neonatal Intensive Care Units
下载PDF
导出
摘要 目的:分析新生儿重症监护病房抗感染药的使用情况和细菌培养及耐药情况,促进抗感染药的合理使用。方法:对2005年新生儿重症监护病房抗感染药的使用和细菌培养及耐药情况进行回顾性分析。结果:我院新生儿重症监护病房主要检出菌:革兰阳性球菌以里昂葡萄球菌为主,其次为溶血葡萄球菌;革兰阴性杆菌主要是大肠埃希菌、铜绿假单胞菌、肺炎克雷伯菌和鲍曼不动杆菌。用药以头孢菌素类药物为第一位,使用频次最高的药物是头孢吡肟,亚胺培南对革兰阴性杆菌仍是最敏感药物,万古霉素对葡萄球菌是最敏感药物。结论:临床应加强抗感染药的使用管理,控制细菌耐药性的产生。 Objective: To study antibiotics application and drug tolerance from neonatal intensive care units. Method: Sputa from NICU were cultured, bacterial strains were isolated and identified, drug tolerance was characterized in 2005, and drug application was statistically analyzed. Result: The main gram-positive bacteria were staphylococcus lugdunensis and staphylococcus hemolyticus. The main pathogens were escherichia coli, pseudomonas aeruginosa, Klebsiella pneumonia and acinetobacter baumannii. The main drugs for the treatment were cephalothin. Imipenem was the most active antibiotic against the gram-negative and norvancomycin was the most active antibiotic against the gram-positive. Conclusion: In order to control the resistance of bacterial, appropriate use of antibiotics must be strengthened.
作者 刘真 赵金辉
出处 《药物流行病学杂志》 CAS 2007年第4期230-233,共4页 Chinese Journal of Pharmacoepidemiology
关键词 抗感染药 新生儿 耐药性 Antibiotics Neonatal Drug tolerance
  • 相关文献

参考文献7

二级参考文献32

  • 1宁德俄,常翠,刘春,曹伟灵,张华翔,董淳.923份住院病历抗菌药使用情况调查分析[J].药物流行病学杂志,2004,13(6):338-340. 被引量:29
  • 2吴笑春.遏制致病菌对抗菌药物的耐药(上)[J].中国药师,2006,9(1):33-35. 被引量:26
  • 3Hussain Z, Stoakes L, Garrow S, et al. Rapid detection of mecA-positive and mecA-negative coagulase-negative staphylococci by an anti-penicillin binding protein 2a slide latex agglutination test. J Clin Microbiol, 2000,38(6) : 2051.
  • 4Trine G, Claus K, Trond F, et al. Rapid detection of the methicillin-resistance gene, mecA, in coagulase-negative staphylococci. Scand J Infect Dis,2001,33(7) :502.
  • 5De Neeling AJ, van Leeuwen WJ, Schouls LM, et al. Resistance of staphylococci in the Netherlands: surveillance by an electronic network during 1989-- 1995. J Antimicrob Chemother, 1998,41(1) :93.
  • 6Voss A, Kresken M. Antibiotic resistance in staphylococci in Europe. Chemotherapy, 1996,42(suppl 2) : 13.
  • 7Coleman K, Athalye M, Clancey A, et al. Bacterial resistance mechanisms as therapeutics target. J Arltimicrob Chemother, 1994,33(6) : 1091.
  • 8Pascual A, Ramirez de, Arellano E, et al. Activity of glycopeptides in combination with amikacin or rifampin against staphylococcus epidermidis biofilms or plastic catheters. Eur J Clin Microbiol Infect Dis, 1994,13(6) :515.
  • 9Srinivasan A, Dick JD, Perl, TM. Vancomycin resistance in staphylococci. Clin Microbiol Rev,2002,15(3) :430.
  • 10Petinaki E, Kontos F, Miriagou V, et al. Survey of methicillin-resistant coagulase-negative staphylococci in the hospitals of central Greece. Intern J Antimicrob Agents, 2001,18(6) : 563.

共引文献582

同被引文献35

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部